Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?

PURPOSE OF REVIEW: Exciting pre-clinical data presents pluripotent stem cell-derived cardiomyocytes (PSC-CM) as a novel therapeutic prospect following myocardial infarction, and worldwide clinical trials are imminent. However, despite notable advances, several challenges remain. Here, we review PSC-...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvakumar, Dinesh, Reyes, Leila, Chong, James J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Regenerative Medicine (SM Wu, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068652/
https://www.ncbi.nlm.nih.gov/pubmed/35275365
http://dx.doi.org/10.1007/s11886-022-01666-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068652/
https://www.ncbi.nlm.nih.gov/pubmed/35275365
http://dx.doi.org/10.1007/s11886-022-01666-9

Ejemplares similares